SIM
NGNE icon

Spark Investment Management’s Neurogene NGNE Stock Holding History

Spark Investment Management’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-941
Closed -$214K – 201
2020
Q1 		$214K Buy
+941
New +$194K 0.11% 225
2019
Q3 		– Sell
-2,320
Closed -$109K – 476
2019
Q2 		$109K Sell
2,320
-1,956
-46% -$101K 0.01% 498
2019
Q1 		$230K Buy
4,276
+228
+6% +$11.5K 0.01% 480
2018
Q4 		$174K Buy
4,048
+2,112
+109% +$103K 0.01% 515
2018
Q3 		$113K Buy
+1,936
New +$114K 0.01% 603
2015
Q3 		– Sell
-600
Closed -$83K – 726
2015
Q2 		$83K Sell
600
-190
-24% -$28.9K 0.01% 607
2015
Q1 		$129K Buy
790
+215
+37% +$43.7K 0.02% 595
2014
Q4 		$86K Buy
+575
New +$81.9K 0.01% 594
2014
Q2 		– Sell
-780
Closed -$197K – 703
2014
Q1 		$197K Buy
+780
New +$201K 0.03% 531

Other funds holding NGNE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Spark Investment Management's NGNE Position: Q2 2020 in Review

Spark Investment Management sold out of Neurogene (NGNE) in Q2 2020, closing a stake of 941 shares — an estimated $214K sold.

Spark Investment Management first reported a position in NGNE in Q1 2014 and held it in 9 quarters. The position peaked at $230K in Q1 2019. 74 funds tracked by Wall St. Rank hold NGNE as of Q2 2020.

  • Spark Investment Management reported no remaining Neurogene position as of Q2 2020 after selling out during the quarter.
  • Spark Investment Management sold 941 Neurogene shares in Q2 2020, an estimated $214K.
  • Spark Investment Management first reported a position in Neurogene in Q1 2014 and held it in 9 quarters.
  • Spark Investment Management's Neurogene position peaked at $230K in Q1 2019.
  • 74 funds tracked by Wall St. Rank held Neurogene as of Q2 2020.

Based on Spark Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.